Laparoscopy Acceptable for Staging Uterine Cancer

This article originally appeared here.
Share this content:
Laparoscopy Acceptable for Staging Uterine Cancer
Laparoscopy Acceptable for Staging Uterine Cancer

(HealthDay News) – Comprehensive surgical staging of endometrial cancer can be performed laparoscopically with relatively small differences in recurrence rates compared to laparotomy, according to a study published online January 30 in the Journal of Clinical Oncology.

Joan L. Walker, MD, of the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues randomly assigned patients with clinical stages I to IIA uterine cancer in a 2:1 ratio to laparoscopy (1,696 women) vs. laparotomy (920 women) for hysterectomy, salpingo-oophorectomy, pelvic cytology, and pelvic and para-aortic lymphadenectomy. Noninferiority of recurrence-free interval was the primary end point, and was defined as no more than a 40% increase in the risk of recurrence with laparoscopy vs. laparotomy.

The researchers found that, over a median of 59 months of follow-up, there were 309 recurrences (210 laparoscopy; 99 laparotomy) and 350 deaths (229 laparoscopy; 121 laparotomy). For laparoscopy versus laparotomy, the estimated hazard ratio was 1.14 (90% lower bound, 0.92; 95% upper bound, 1.46), which did not meet the pre-specified noninferiority criteria. The actual recurrence rates were substantially lower than expected, with an estimated three-year recurrence rate of 11.4 and 10.2% with laparoscopy and laparotomy, respectively (difference of 1.14%; 90% lower bound, −1.28; 95% upper bound, 4.0). An almost identical five-year overall survival, 89.8%, was seen in both groups.

"The potential for increased risk of cancer recurrence with laparoscopy vs. laparotomy was quantified and found to be small, providing accurate information for decision making for women with uterine cancer," the authors write.

Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs